|
Symbol Name ID |
Insig1
insulin induced gene 1 MGI:1916289 |
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Insig1tm1.1Mbjg/Insig1tm1.1Mbjg Insig2tm1Mbjg/Insig2+ involves: 129S6/SvEvTac * C57BL/6NCrl * FVB/N |
postnatal lethality | J:101203 |
| Insig1tm1.1Mbjg/Insig1tm1.1Mbjg Insig2tm1Mbjg/Insig2tm1Mbjg involves: 129S6/SvEvTac * C57BL/6NCrl * FVB/N |
postnatal lethality | J:101203 |
| Insig1tm1Mbjg/Insig1tm1Mbjg Insig2tm1Mbjg/Insig2tm1Mbjg Tg(Mx1-cre)29-4Her/0 involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl * SJL |
abnormal cholesterol homeostasis | J:101203 |
| abnormal hepatobiliary system physiology | J:101203 | |
| abnormal lipid homeostasis | J:101203 | |
| abnormal liver morphology | J:101203 | |
| decreased circulating triglyceride level | J:101203 | |
| increased circulating cholesterol level | J:101203 | |
| increased fatty acids level | J:101203 | |
| increased liver cholesterol level | J:101203 | |
| increased liver triglyceride level | J:101203 | |
| pale liver | J:101203 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||